Alembic Pharmaceuticals Limited
Records under this name other than the patents Alembic Pharmaceuticals Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 7 of 7 · Back to Alembic Pharmaceuticals Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,071,092 | Novel Polymorphic Forms of Vortioxetine and Its Pharmaceutically Acceptable Salts Lapsed on the fee record Ended Sep 11, 2026 · High confidence | Lapsed on the fee record | Ended Sep 11, 2026 | High confidence |
| US 9,493,443 | Process for the preparation of vilazodone hydrochloride and its amorphous form Lapsed on the fee record Ended Nov 15, 2024 · From the USPTO record | Lapsed on the fee record | Ended Nov 15, 2024 | From the USPTO record |
| US 10,399,942 | Process and novel polymorphic form of Apremilast Lapsed on the fee record Ended Sep 3, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 3, 2023 | From the USPTO record |
| US 9,085,509 | Process for preparing fesoterodine Lapsed on the fee record Ended Jul 21, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 21, 2023 | From the USPTO record |
| US 9,018,389 | Process for the preparation of Deferasirox Lapsed on the fee record Ended Apr 28, 2023 · From the USPTO record | Lapsed on the fee record | Ended Apr 28, 2023 | From the USPTO record |
| US 9,969,721 | Process for the preparation of vilazodone hydrochloride and its amorphous form Lapsed on the fee record Ended May 15, 2022 · From the USPTO record | Lapsed on the fee record | Ended May 15, 2022 | From the USPTO record |
| US 9,440,910 | Reference markers for fesoterodine fumarate Lapsed on the fee record Ended Sep 13, 2020 · From the USPTO record | Lapsed on the fee record | Ended Sep 13, 2020 | From the USPTO record |